GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » Other Net Income (Loss)

PharmaTher Holdings (XCNQ:PHRM) Other Net Income (Loss) : C$0.00 Mil (TTM As of Feb. 2025)


View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings Other Net Income (Loss)?

PharmaTher Holdings's Other Net Income (Loss) for the three months ended in Feb. 2025 was C$0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Feb. 2025 was C$0.00 Mil.

PharmaTher Holdings's annual Other Net Income (Loss) declined from May. 2021 (C$0.00 Mil) to May. 2022 (C$0.00 Mil) but then stayed the same from May. 2022 (C$0.00 Mil) to May. 2023 (C$0.00 Mil).


PharmaTher Holdings Other Net Income (Loss) Historical Data

The historical data trend for PharmaTher Holdings's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Other Net Income (Loss) Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23
Other Net Income (Loss)
- - -

PharmaTher Holdings Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 Aug24 Nov24 Feb25
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PharmaTher Holdings Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Feb. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaTher Holdings Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaTher Holdings Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.
Executives
Fabio Chianelli Director, Senior Officer

PharmaTher Holdings Headlines

No Headlines